7.4 Immunogenicity & Antigen Prevalence

Immunogenicity & Antigen Prevalence

Quick Answer: Not all blood group antigens are equally likely to provoke an antibody response. Immunogenicity depends on antigen structure (protein versus carbohydrate), copy number on the cell surface, and how foreign the antigen is to the recipient's immune system, producing a well-established hierarchy topped by ABO, then D, then K (Kell), followed by the remaining Rh antigens and other protein antigens such as Fya, Jka, and S. Zygosity adds another layer through the dosage effect, in which antibodies react more strongly against red cells carrying a double dose (homozygous expression) of the corresponding antigen than against cells with a single dose (heterozygous expression). Antigen prevalence — how common an antigen is in the general population — determines a different practical problem: whether an antibody will be easy to identify but hard to support with compatible blood (high-prevalence antigens) or easy to support but hard to catch on a screen (low-prevalence antigens).

The Immunogenicity Hierarchy

Among all human blood group antigens, the ABO antigens are effectively universal immunogens because virtually everyone who lacks an ABO antigen has naturally occurring antibody against it, driven by environmental exposure to cross-reactive carbohydrate structures on gut bacteria. Setting ABO aside as a special case, D is the single most immunogenic protein red cell antigen: an RhD-negative person transfused with even a small volume of RhD-positive red cells has a substantial probability of forming anti-D, which is why Rh matching is mandatory practice and why RhIG prophylaxis exists specifically to prevent D alloimmunization in pregnancy. K (Kell) ranks next in immunogenicity among the non-ABO/Rh antigens; despite being present in only about 9% of the population, K provokes antibody formation often enough that Kell compatibility is sometimes considered for chronically transfused or pregnant patients at elevated risk. Below K, the remaining Rh antigens (c, E, e, C) and other protein-based antigens such as Fya, Jka, Jkb, and S are meaningfully immunogenic but considerably less so than D or K. Carbohydrate-based antigens — including Lewis, P1, and I — are, with the important exception of ABO itself, generally poor immunogens as alloantibodies because the immune system tends to treat widely shared carbohydrate epitopes as less foreign, and because these antigens are often soluble or weakly expressed rather than being densely packed integral membrane proteins.

What Determines Immunogenicity

Several overlapping factors explain why some antigens provoke antibodies far more readily than others. Structural foreignness matters most: the greater the biochemical difference between a donor's antigen and the corresponding structure, or absence of structure, in the recipient, the more effectively the immune system recognizes it as non-self. Molecular class matters too — protein antigens such as Rh, Kell, Duffy, and Kidd antigens are generally more immunogenic than carbohydrate antigens because proteins are efficiently processed and presented by antigen-presenting cells to helper T cells, enabling a robust, class-switched IgG response, whereas carbohydrate antigens tend to provoke T-cell-independent, largely IgM responses. Antigen copy number, or density on the red cell surface, also contributes; more copies mean more opportunity for immune recognition and cross-linking of B-cell receptors. Route, dose, and frequency of exposure matter as well — a single large-volume transfusion, repeated smaller transfusions, and pregnancy all create different immunization risk profiles. Finally, host genetics play a role: HLA Class II alleles influence how efficiently an individual's antigen-presenting cells display a given foreign peptide to helper T cells, which is part of why some multiply-transfused patients never form alloantibodies while others form several.

The Dosage Effect

Dosage refers to the observation that certain antibodies react more strongly, or only react at all, against red cells that are homozygous for the corresponding antigen (a double dose) compared with heterozygous cells (a single dose). This effect is well documented for the Rh system (particularly e and C), the Kidd system, the Duffy system, and the MNS system. The practical consequence is significant: a weakly reactive antibody such as anti-Jka may agglutinate Jk(a+b-) (homozygous, double-dose) panel cells clearly while failing to react, or reacting only weakly, with Jk(a+b+) (heterozygous, single-dose) cells. A technologist who only has access to heterozygous-expressing panel cells risks missing a clinically significant antibody altogether, which is one reason comprehensive antibody panels are constructed to include, whenever possible, both homozygous and heterozygous expression for antigens known to show dosage.

Antigen Prevalence and Its Practical Consequences

Prevalence and immunogenicity are independent properties, and conflating them is a common error. A highly immunogenic antigen that is also high-prevalence, like D, produces antibodies that are both easy to detect (most panel cells are D-positive) and hard to support with compatible blood (D-negative units are the minority). A highly immunogenic but low-prevalence antigen, like K, produces antibodies that are comparatively easy to support (most donors are K-negative) once identified. Antigens at either extreme of the prevalence spectrum — high-prevalence public antigens and low-prevalence private antigens — create their own distinct laboratory challenges independent of how immunogenic they are, as seen with Ge, Yta, Vel, Wra, and Kpa: public-antigen antibodies are hard to support transfusion-wise because compatible units are scarce, while private-antigen antibodies are hard to detect because standard screening cells rarely express the antigen in the first place. Recognizing which axis — immunogenicity or prevalence — is driving a particular case is central to efficient antibody identification and to selecting compatible blood under time pressure.

Quick Reference